BUSABrandes U.S. Value ETF
Seeks long term capital appreciation.
By Brandes · Launched 2023
Annual Cost
0.60%
#3,337 of 6,040 · average
Fund Size
$325M
#2,006 of 6,040 · large
Return (1Y)
+20.1%
Track Record
2 years
#3,157 of 6,040 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$11,977+19.8%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundHoldings
By weightConcentration
Top 10 holdings = 24.4% of funddiversified
Merck & Co., Inc
2.9%
Citigroup Inc.
2.8%
Textron Inc.
2.5%
Pfizer Inc.
2.4%
FedEx Corporation
2.4%
Bank of America Corp.
2.4%
Halliburton Company
2.4%
CHEVRON CORP
2.3%
The Cigna Group
2.2%
Becton, Dickinson and Company
2.2%
Asset allocation
Stocks
97.9%
Cash
2.1%
By sector
Healthcare
25.6%
Financial Services
22.9%
Industrials
12.1%
Technology
10.1%
Energy
6.1%
Communication
5.7%
Consumer Cyclical
5.5%
Consumer Defensive
5.2%
Other
6.9%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
11.9%Moderate
Year-on-year price swings
Max drawdown
-14.2%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks long term capital appreciation.
- Strategy
- Actively manages a portfolio primarily invested in equity securities of U.S. companies, focusing on undervalued stocks based on intrinsic value analysis. Typically targets companies with market capitalizations greater than $5 billion.
- Inception date
- October 3, 2023
- Fund family
- Brandes
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save BUSA to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18